Interim Results from a Phase I Randomized, Placebo-Controlled Trial of Novel SARS-CoV-2 Beta Variant Receptor-Binding Domain Recombinant Protein and Mrna Vaccines As a 4th Dose Booster.
EBIOMEDICINE（2023）
关键词
SARS-CoV-2,Vaccine,Receptor binding domain,Recombinant protein,mRNA,Beta variant,Phase I trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要